Literature DB >> 9188052

Perifollicular transgenic expression of human interleukin-1 receptor antagonist protein following topical application of novel liposome-plasmid DNA formulations in vivo.

S M Niemiec1, J M Latta, C Ramachandran, N D Weiner, B J Roessler.   

Abstract

Expression plasmid DNA for the human interleukin-1 receptor antagonist (IL-1ra) protein was formulated with nonionic:cationic (NC) liposomes or phosphatidylcholine:cationic (PC) liposomes and applied to the auricular skin of hamsters in single- and multiple-dose protocols. Confocal microscopy identified delivery of plasmid DNA proximal to perifollicular cells, and successful transfection of perifollicular cells was identified by immunohistochemistry and ELISA. Skin treated for 3 days with the NC liposomes had statistically significant levels of transgenic IL-1ra present for 5 days post-treatment. Expression of transgenic IL-1ra was specific to areas of skin treated with NC liposomes but not PC liposomes. The results indicate that the NC liposomes can deliver expression plasmid DNA to perifollicular cells and mediate transient transfection in vivo.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9188052     DOI: 10.1021/js9604873

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  7 in total

1.  Topical application of plasmid DNA to mouse and human skin.

Authors:  Nuschin Meykadeh; Alireza Mirmohammadsadegh; Zhijun Wang; Etiena Basner-Tschakarjan; Ulrich R Hengge
Journal:  J Mol Med (Berl)       Date:  2005-05-19       Impact factor: 4.599

2.  Enhancement of topical delivery from biodegradable nanoparticles.

Authors:  Rocío Alvarez-Román; Aarti Naik; Yogeshvar N Kalia; Richard H Guy; Hatem Fessi
Journal:  Pharm Res       Date:  2004-10       Impact factor: 4.200

3.  Topical delivery of siRNA into skin using SPACE-peptide carriers.

Authors:  Ming Chen; Michael Zakrewsky; Vivek Gupta; Aaron C Anselmo; Deborah H Slee; John A Muraski; Samir Mitragotri
Journal:  J Control Release       Date:  2014-01-13       Impact factor: 9.776

4.  Liposomal formulations of inflammatory bowel disease drugs: local versus systemic drug delivery in a rat model.

Authors:  Filippos Kesisoglou; Simon Yuji Zhou; Susan Niemiec; Jordan Wing Lee; Ellen M Zimmermann; David Fleisher
Journal:  Pharm Res       Date:  2005-08-03       Impact factor: 4.200

5.  Hydroxyzine from topical phospholipid liposomal formulations: evaluation of peripheral antihistaminic activity and systemic absorption in a rabbit model.

Authors:  Abeer A W Elzainy; Xiaochen Gu; F Estelle R Simons; Keith J Simons
Journal:  AAPS PharmSci       Date:  2003-11-05

6.  Skin Delivery of siRNA Using Sponge Spicules in Combination with Cationic Flexible Liposomes.

Authors:  XueJiao Liang; JiaLiang Zhang; HuiLong Ou; Jun Chen; Samir Mitragotri; Ming Chen
Journal:  Mol Ther Nucleic Acids       Date:  2020-04-18       Impact factor: 8.886

7.  Novel ethanol-in-fluorocarbon microemulsions for topical genetic immunization.

Authors:  Zhengrong Cui; William Fountain; Michael Clark; Michael Jay; Russell J Mumper
Journal:  Pharm Res       Date:  2003-01       Impact factor: 4.200

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.